MRFAP1L1 抗体 (AA 1-127) (FITC)
Quick Overview for MRFAP1L1 抗体 (AA 1-127) (FITC) (ABIN1993181)
抗原
See all MRFAP1L1 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-127
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human MORF4 family-associated protein 1-like 1 protein (1-127AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working concentration should be determinde by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClinTM: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            注意事项
- Avoid repeated freeze.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - MRFAP1L1 (Morf4 Family Associated Protein 1-Like 1 (MRFAP1L1))
- 
                                            别名
- MRFAP1L1
- 
                                            背景
- MORF4 family-associated protein 1-like 1 antibody, MR1L1_HUMAN antibody, MRFAP1L1 antibody, PP784 antibody
- 
                                            UniProt
- Q96HT8
 抗原
- 
                    
 
                                     
                                     
                                    